On Thursday, the Food and Drug Administration approved Cobenfy, a drug from Bristol Myers Squibb—the first truly novel treatment for schizophrenia in decades.
FDA Approves Potentially Groundbreaking Schizophrenia Drug
Read Also
- Microsoft Details All the Ways You Can Ignore Recall on Copilot+ PCs
- Microsoft announces sweeping changes to controversial Recall feature for Windows 11 Copilot+ PCs
- Trimer complex TaNF-Y balances grain yield and quality in wheat: Study
- Microsoft’s more secure Windows Recall feature can also be uninstalled by users
- Today is your last chance to save on Disney Plus before the password sharing crackdown
- Scientists use drones to track white sharks along California beaches
- Teacher strikes are effective in increasing wages, working conditions, study finds
- Gambling marketing and the Premier League—the continued failure of industry self-regulation
- VXS-1 Squadron continues the mission, tracking potential tropical cyclone
- Multi-state study offers recommendations for keeping bermudagrass greener all season
Latest Gizmodo
- Microsoft Details All the Ways You Can Ignore Recall on Copilot+ PCs
- Earth Might Escape Annihilation When Our Sun Dies, Study Shows
- Fitness Freaks: You Can Save Up to $75 When You Pre-order the Samsung Galaxy Watch FE
- Two of the Best Animated Films of the Year Are Now in Theaters
- Students Can Pre-order the Samsung Galaxy S24 FE and Get the Galaxy Buds FE for Free
- FDA Approves Potentially Groundbreaking Schizophrenia Drug
- Google Did the Inevitable: Gave All its Pixel Buds Gemini Integration
- Human Feedback Makes AI Better at Deceiving Humans, Study Shows
- LG Is Slashing Prices On Their Top Appliances By Hundreds — Even Thousands
- Despite Sony’s Efforts, the Scalpers Won the PlayStation 5 Pro Launch